Recent and Important Publications
- Giblett JP et al. Post-infarction ventricular septal defect: percutaneous or surgical management in the UK national registry. European Heart Journal. 2022.
- Giblett JP et al. Transcatheter Versus Surgical Management of Paravalvular Leak: A Single-Center Experience With Purpose-Specific Occluders. JACC: Cardiovascular Interventions. 2022
- Giblett JP et al. Percutaneous management of paravalvular leaks. Heart. 2022
- Bambrough P, Peverelli M, Brown AJ, Giblett JP, Bennett MR, West NEJ, Hoole SP. Trans-myocardial blood Interleukin-6 levels relate to intracoronary imaging defined features of plaque vulnerability and predict procedure-induced myocardial infarction. Cardiovascular Revascularization Medicine. 2022
- Aetesam‐ur‐Rahman M, Brown AJ, Jaworski C, Giblett JP, Zhao TX, Braganza DM, Clarke SC, Agrawal BSK, Bennett MR, West NEJ, Hoole SP. Adenosine‐Induced Coronary Steal Is Observed in Patients Presenting With ST‐Segment–Elevation Myocardial Infarction. Journal of the American Heart Association. 2021
- Hung J, Giblett JP. Iatrogenic Aortocoronary Dissection During Percutaneous Coronary Intervention: Investigation and Management. JACC: Case Reports. 2021
- Giblett JP et al. Patent Foramen Ovale Closure: State of the Art. Interventional Cardiology Review. 2020.
- Węglarz P, Spisak-Borowska K, Bochenek T, Konarska-Kuszewska E, Machowski J, Trusz-Gluza M, Bajor G, Mizia-Stec K, Giblett JP*, Calvert PA*. Impact of percutaneous patent foramen ovale closure on migraine headaches in patients with history of ischemic neurological events. Advances in Interventional Cardiology. 2020.
- Aetesam-ur-Rahman M, Giblett JP, Khialani B, Kyranis S, Clarke SJ, Zhao TX, Braganza DM, Clarke SC, West NEJ, Bennett MR, Hoole SP. GLP-1 vasodilatation in humans with coronary artery disease is not adenosine mediated. BMC Cardiovascular Disorders. 2021
- Giblett JP Bulluck H. Cardioprotection for Acute MI in Light of the CONDI2/ERIC-PPCI Trial: New Targets Needed. Interventional Cardiology Review. 2020
- Giblett JP. Does Impella Support Really Prevent Catastrophe? JACC: Case Reports. 2020
- Klementowicz P, Giblett JP, Agrawal SKB, Shapiro LM, Calvert PA. A Giant Saphenous Vein Graft Aneurysm Treated with Percutaneous Closure. JACC: Case Reports. 2019
- Giblett JP et al. Transcatheter treatment of postinfarct ventricular septal defects. Heart. 2020.
- Rubini-Gimenez M, Giblett JP. Are Vasopressors an Enemy of the Coronary Arteries? JACC: Case Reports. 2019.
- Giblett JP et al. The role of Glucagon-Like Peptide 1 Loading on periprocedural myocardial infarction During elective PCI (GOLD-PCI study): a randomized, placebo-controlled trial. American Heart Journal. 2019.
- Orzalkiewicz M, Hodson J, Kwok CS, Ludman PF, Giblett JP, Sudhakar G, Doshi SN, Khan SQ, Kinnaird T, Hildick-Smith D, Townend JN, Mamas MA, Calvert PA. Comparison of Routine Versus Selective Glycoprotein IIb/IIIa Inhibitors Usage in Primary Percutaneous Coronary Intervention (from the British Cardiovascular Interventional Society). American Journal of Cardiology. 2019.
- Giblett JP et al. Patent Foramen Ovale Closure in 2019. Interventional Cardiology Review. 2019
- Clarke SJ, Pettit S, Giblett JP, Zhao TX, Kydd AC, Albrechtsen NJW, Deacon CF, Parameshwar J, Hoole SP. Effects of Acute GLP-1 Infusion on Pulmonary and Systemic Hemodynamics in Patients With Heart Failure: A Pilot Study. Clinical Therapeutics. 2018.
- Flore V, Brown A, Giblett JP, Liou K, Cranley J, Hoole SP, West NEJ. Clinical outcomes of bioresorbable vascular scaffolds implanted with routine versus selective optical coherence tomography guidance: results from a single-center experience. Eurointervention. 2018.
- Giblett JP et al. Percutaneous management of paravalvular leaks. Nat Rev Cardiology. 2019.
- Giblett JP et al. Glucagon-Like Peptide-1–Mediated Cardioprotection Does Not Reduce Right Ventricular Stunning and Cumulative Ischemic Dysfunction After Coronary Balloon Occlusion. JACC: Basic to Translational Science. 2019.
- Clarke SJ, Giblett JP, Yang L, Hubsch A, West NEJ, O’Sullivan M, Figg N, Bennett MR, Zhao TX, Wewer-Albrechtson NJ, Deacon CF, Cheriyan J, Hoole SP. GLP-1 is a Coronary Artery Specific Vasodilator in Humans. Journal of the American Heart Association. 2018.
- Hoole SP, Hernández-Sánchez J, Brown AJ, Giblett JP, Bennett MR, West NEJ. Prediction of postpercutaneous coronary intervention myocardial infarction: insights from intravascular imaging, coronary flow, and biomarker evaluation. Coronary artery disease. 2018
- Brown AJ, Giblett JP, Bennett MR, West NEJ, Hoole SP. Anatomical plaque and vessel characteristics are associated with hemodynamic indices including fractional flow reserve and coronary flow reserve: A prospective exploratory intravascular ultrasound analysis. International Journal of Cardiology. 2017.
- Axell RG*, Giblett JP*, White PA, Klein A, Hampton-Til J, O’Sullivan M, Braganza D, Davies WR, West NE, Densem CG, Hoole SP. Stunning and Right Ventricular Dysfunction is Induced by Coronary Balloon Occlusion and Rapid Pacing in Humans: Insights from Right Ventricular Conductance Catheter Studies. Journal of the American Heart Association. 2017.
- Axell RG, White PA, Giblett JP, Williams LK, Rana BR, Klein AK, O’Sullivan M, Davies WR, Densem CG, Hoole SP. Rapid Pacing Induced Right Ventricular Dysfunction is Evident after Balloon Expandable Trans-femoral Aortic Valve Replacement. JACC. 2017
- Ha FJ, Giblett JP, Nerlekar N, Cameron JD, Meredith IT, West NEJ, Brown AJ. Optical Coherence Tomography Guided Percutaneous Coronary Intervention. Heart, Lung and Circulation. 2017.
- Giblett JP, Hoole SP. Remote Ischemic Conditioning in Elective PCI? Journal of Cardiovascular Pharmacology and Therapeutics. 2017.
- Giblett JP et al.. Early disarticulation of a Bioresorbable Vascular Scaffold: an underreported consequence of repeat imaging. Cardiovascular Intervention and Therapeutics. 2017.
- Giblett JP et al. Glucagon-like Peptide-1 derived cardioprotection does not utilize a KATP-channel dependent pathway: mechanistic insights from human supply and demand ischemia studies. Cardiovascular Diabetology. 2016.
- Giblett JP et al. Glucagon-like Peptide-1: a promising agent for cardioprotection during myocardial ischemia. JACC: Basic to Translational Science. 2016.
- Giblett JP et al. Implantation of bioresorbable vascular scaffolds following acute coronary syndrome is associated with reduced early neointimal growth and strut coverage. Eurointervention. 2016.
- Giblett JP et al. Cardioprotection for Percutaneous Coronary Intervention–Reperfusion Quality as well as Quantity. International Journal of Cardiology. 2014
- McCormick LM, Brown AJ, Ring LS, Gajendragadkar PR, Dockrill SJ, Hansom SP, Giblett JP, Gilbert TJ, Hoole SP, West NE. Direct stenting is an independent predictor of improved survival in patients undergoing primary percutaneous coronary intervention for ST elevation myocardial infarction. European Heart Journal: Acute Cardiovascular Care. 2014.
- Kyriakou T, Pontefract D, Viturro E, Hodgkinson CP, Laxton RC, Bogari N, Cooper G, Davies M, Giblett J, Day INM, Simpson IA, Albrecht C and Ye S. Functional polymorphism in ABCA1 influences age of symptom onset in coronary artery disease patients. Human Molecular Genetics. 2007.